22-23787170-A-G

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PVS1_SupportingBP6BS2

The NM_003073.5(SMARCB1):​c.1A>G​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000931 in 1,589,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000082 ( 0 hom. )

Consequence

SMARCB1
NM_003073.5 start_lost

Scores

4
6
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6O:1

Conservation

PhyloP100: 2.92

Publications

7 publications found
Variant links:
Genes affected
SMARCB1 (HGNC:11103): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1) The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be a tumor suppressor, and mutations in it have been associated with malignant rhabdoid tumors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]
SMARCB1 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • intellectual disability, autosomal dominant 15
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • rhabdoid tumor predisposition syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Genomics England PanelApp, G2P
  • SMARCB1-related schwannomatosis
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics
  • familial multiple meningioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • schwannomatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PVS1
Start lost variant, no pathogenic variants between lost start and next in-frame start position. Next in-frame start position is after 2 codons. Genomic position: 23787173. Lost 0.003 part of the original CDS.
BP6
Variant 22-23787170-A-G is Benign according to our data. Variant chr22-23787170-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 135257.
BS2
High AC in GnomAd4 at 30 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003073.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCB1
NM_003073.5
MANE Select
c.1A>Gp.Met1?
start_lost
Exon 1 of 9NP_003064.2
SMARCB1
NM_001362877.2
c.1A>Gp.Met1?
start_lost
Exon 1 of 9NP_001349806.1
SMARCB1
NM_001317946.2
c.1A>Gp.Met1?
start_lost
Exon 1 of 9NP_001304875.1G5E975

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCB1
ENST00000644036.2
MANE Select
c.1A>Gp.Met1?
start_lost
Exon 1 of 9ENSP00000494049.2Q12824-1
SMARCB1
ENST00000407422.8
TSL:1
c.1A>Gp.Met1?
start_lost
Exon 1 of 9ENSP00000383984.3Q12824-2
SMARCB1
ENST00000263121.12
TSL:1
c.1A>Gp.Met1?
start_lost
Exon 1 of 8ENSP00000263121.8A0A0G2JRV3

Frequencies

GnomAD3 genomes
AF:
0.000197
AC:
30
AN:
152042
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000164
AC:
40
AN:
243496
AF XY:
0.000158
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00142
Gnomad EAS exome
AF:
0.0000568
Gnomad FIN exome
AF:
0.000880
Gnomad NFE exome
AF:
0.0000365
Gnomad OTH exome
AF:
0.000168
GnomAD4 exome
AF:
0.0000821
AC:
118
AN:
1437312
Hom.:
0
Cov.:
29
AF XY:
0.0000852
AC XY:
61
AN XY:
716004
show subpopulations
African (AFR)
AF:
0.0000308
AC:
1
AN:
32416
American (AMR)
AF:
0.00
AC:
0
AN:
44074
Ashkenazi Jewish (ASJ)
AF:
0.00198
AC:
51
AN:
25774
East Asian (EAS)
AF:
0.000232
AC:
9
AN:
38832
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85182
European-Finnish (FIN)
AF:
0.000532
AC:
28
AN:
52620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5708
European-Non Finnish (NFE)
AF:
0.0000183
AC:
20
AN:
1093298
Other (OTH)
AF:
0.000135
AC:
8
AN:
59408
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000197
AC:
30
AN:
152042
Hom.:
0
Cov.:
34
AF XY:
0.000350
AC XY:
26
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41440
American (AMR)
AF:
0.00
AC:
0
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3468
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67962
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000847
Hom.:
0
Bravo
AF:
0.0000302
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000990
AC:
12

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not provided (2)
-
-
1
Rhabdoid tumor predisposition syndrome 1 (1)
-
1
-
Rhabdoid tumor predisposition syndrome 1;C3553248:Intellectual disability, autosomal dominant 15;C4048809:SMARCB1-related schwannomatosis (1)
-
-
1
SMARCB1-related schwannomatosis (1)
-
-
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.17
D
BayesDel_noAF
Pathogenic
0.19
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.27
T
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.17
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.98
D
MetaRNN
Benign
0.23
T
MetaSVM
Uncertain
0.30
D
PhyloP100
2.9
PROVEAN
Benign
-0.41
N
REVEL
Uncertain
0.61
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.056
T
Polyphen
0.0
B
Vest4
0.82
MVP
0.98
ClinPred
0.41
T
GERP RS
2.4
PromoterAI
-0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.89
gMVP
0.38
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs367768260; hg19: chr22-24129357; API